Alkermes` Corporate Presentation to be Webcast at Two Upcoming Conferences
Alkermes’ Corporate Presentation to be Webcast at Two Upcoming Conferences
Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the Jefferies 2012 Global Healthcare Conference on Wednesday, November 14, 2012, at 9:20 a.m. GMT (4:20 a.m. EST) in London. In addition, Alkermes’ corporate presentation will be webcast live at the Credit Suisse 2012 Healthcare Conference on Wednesday, November 14, 2012, at 3:00 p.m. MST (5:00 p.m. EST/10:00 p.m. GMT) from Phoenix, Arizona. These presentations may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.
Alkermes plc is a fully integrated, global biopharmaceutical company that applies its scientific expertise and proprietary technologies to develop innovative medicines that improve patient outcomes. The company has a diversified portfolio of more than 20 commercial drug products and a substantial clinical pipeline of product candidates that address central nervous system (CNS) disorders such as addiction, schizophrenia and depression. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and manufacturing facilities in Gainesville, Georgia and Wilmington, Ohio. For more information, please visit Alkermes’ website at www.alkermes.com.
Eva Stroynowski, +1 781-609-6823
- Insight: How U.S. spying cost Boeing multibillion-dollar jet contract
- Exclusive: Secret contract tied NSA and security industry pioneer |
- With Fed out of the way, what's next on Wall Street?
- Insight: For Chinese farmers, a rare welcome in Russia's Far East
- Analysis: Lost Brazil order raises threat to Boeing fighter jets